EPHA2 and cancer: Ephrin type-A receptor 2 (EPHA2) is overexpressed in multiple tumors and is associated with poor prognosis, increased metastatic potential, and reduced survival rates in cancer patients.[32,33] In this study, we identified a novel EPHA2 gene mutation (p.R762W) in the kinase domain.